Univest
Univest
  • Markets

  • Nykaa Teams Up With L’Oreal’s Venture Arm as Biocon Clears an MHRA Hurdle

    • September 25, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Nykaa Teams Up With L'Oreal's Venture Arm as Biocon Clears an MHRA Hurdle

    Nykaa partners with L’Oreal’s BOLD fund on Indian beauty brands, Biocon Malaysia clears an MHRA hurdle, Inox Green opens a QIP, and Vascon wins a Rs 660.8 crore Qualcomm order.

    read more

  • Biocon Share Price in Focus as Its Pertuzumab Becomes the First Biosimilar to Win EMA Backing

    • September 21, 2026
    • Posted by: Harsh Piplani
    • Category: News
    No Comments
    Biocon Share Price in Focus as Its Pertuzumab Becomes the First Biosimilar to Win EMA Backing

    Biocon share price is in focus after its Pertuzumab biosimilar, Pebrilzo, became the first such biosimilar to secure a positive CHMP opinion from the EMA.

    read more

  • Biocon Share Price in Focus Today: Biocon Gets FDA Approval for Bevacizumab Biosimilar

    • April 11, 2025
    • Posted by: sachet
    • Category: News
    No Comments
    read more